Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
about
JAK2 inhibitors for myeloproliferative neoplasms: what is next?A portable microfluidic platform for rapid molecular diagnostic testing of patients with myeloproliferative neoplasmsPacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia.Recommendations on the use of ruxolitinib for the treatment of myelofibrosis.Developmental Therapeutics in Myeloproliferative Neoplasms.SOHO State-of-the-Art Update and Next Questions: MPN.Novel Therapies for Myelofibrosis.
P2860
Q38684435-8C009631-69CF-4EF1-827A-5BB3C15027ABQ41447065-565FBA80-859A-457D-A525-9676CA624D74Q47784419-DA18DDBB-67F3-4570-8AA7-A6209DBB0968Q47815810-5F3D7354-BE7A-4DCE-A7DA-59F7323B16E3Q48008083-104563A5-8DF9-4466-B4D3-45C5C0638E77Q49580473-1F62E1A5-DACD-437D-8874-EB6E71FF41FCQ52817185-C912B99D-DCC5-463F-B1B8-837C7511E9D4
P2860
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Myeloproliferative Neoplasms, ...... actice Guidelines in Oncology.
@en
Myeloproliferative Neoplasms, ...... actice Guidelines in Oncology.
@nl
type
label
Myeloproliferative Neoplasms, ...... actice Guidelines in Oncology.
@en
Myeloproliferative Neoplasms, ...... actice Guidelines in Oncology.
@nl
prefLabel
Myeloproliferative Neoplasms, ...... actice Guidelines in Oncology.
@en
Myeloproliferative Neoplasms, ...... actice Guidelines in Oncology.
@nl
P2093
P356
P1476
Myeloproliferative Neoplasms, ...... actice Guidelines in Oncology.
@en
P2093
Bart Scott
Brady L Stein
Catriona Jamieson
Daniel A Pollyea
David S Snyder
Eric Padron
Eunice S Wang
Gabriela Hobbs
Hema Sundar
Ivana Gojo
P304
P356
10.6004/JNCCN.2016.0169
P577
2016-12-01T00:00:00Z